Assessment of contemporary traits in the management of Diabetes in government and private health care sector

Abstract

Type 2 diabetes referred as a chronic metabolic disorder, is highly prevalent worldwide and approximately 522 million peoples till 2030 are likely to be affected in the world, increasing the debt burden especially for underdeveloped countries. There is a higher risk of both short term and long term macro vascular complications in diabetic people which include cardiovascular disease, retinopathy and nephropathy. Moreover, it can lead to episodes of ketoacidosis and hyperosmolar hyperglycemic state. The management of DM requires variety of facilities, evaluation of comorbidities and different treatment modes on the basis of heterogeneity in population. This research is based on analysis of current trends in prescription drugs for management of type 2 diabetes in private and government health care sectors of Karachi. A total of 50 distinct and genuine prescriptions of 50 patients with Type 2 Diabetes mellitus were collected from both the sectors, which were than evaluated for the type of therapy being provided for Type 2 D.M; monotherapy or multiple therapy for the management of diabetes. The existing comorbid conditions and the supplement therapy being provided to avoid future complications were also evaluated. Our results would provide better options to health care sectors for improvement in overall quality of life of patients.